v3.24.3
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2022   78,992        
Balance at beginning of period at Dec. 31, 2022 $ 901,113 $ 842 $ 767,112 $ (1,179) $ 320,517 $ (186,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   282        
Issuance of common stock 493 $ 3 490      
Stock-based compensation 4,271   4,271      
Purchase of treasury stock (in shares)   (1,189)        
Purchase of treasury stock (27,609)         (27,609)
Unrealized gain on hedge instruments, net of tax 188     188    
Net income (loss) 18,270       18,270  
Balance at end of period (in shares) at Apr. 01, 2023   78,085        
Balance at end of period at Apr. 01, 2023 896,726 $ 845 771,873 (991) 338,787 (213,788)
Balance at beginning of period (in shares) at Dec. 31, 2022   78,992        
Balance at beginning of period at Dec. 31, 2022 901,113 $ 842 767,112 (1,179) 320,517 (186,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (49,914)          
Balance at end of period (in shares) at Sep. 30, 2023   78,179        
Balance at end of period at Sep. 30, 2023 840,352 $ 846 783,355 (611) 270,603 (213,841)
Balance at beginning of period (in shares) at Apr. 01, 2023   78,085        
Balance at beginning of period at Apr. 01, 2023 896,726 $ 845 771,873 (991) 338,787 (213,788)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   70        
Issuance of common stock 452 $ 1 451      
Stock-based compensation 5,438   5,438      
Purchase of treasury stock (in shares)   (1)        
Purchase of treasury stock (8)         (8)
Unrealized gain on hedge instruments, net of tax 190     190    
Net income (loss) 5,614       5,614  
Balance at end of period (in shares) at Jul. 01, 2023   78,154        
Balance at end of period at Jul. 01, 2023 908,412 $ 846 777,762 (801) 344,401 (213,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   27        
Issuance of common stock 381 $ 0 381      
Stock-based compensation 5,212   5,212      
Purchase of treasury stock (in shares)   (2)        
Purchase of treasury stock (45)         (45)
Unrealized gain on hedge instruments, net of tax 190     190    
Net income (loss) (73,798)       (73,798)  
Balance at end of period (in shares) at Sep. 30, 2023   78,179        
Balance at end of period at Sep. 30, 2023 $ 840,352 $ 846 783,355 (611) 270,603 (213,841)
Balance at beginning of period (in shares) at Dec. 30, 2023 78,311 78,311        
Balance at beginning of period at Dec. 30, 2023 $ 829,418 $ 848 788,967 (419) 254,616 (214,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   363        
Issuance of common stock 316 $ 4 312      
Stock-based compensation 2,431   2,431      
Purchase of treasury stock (in shares)   (116)        
Purchase of treasury stock (2,721)         (2,721)
Unrealized gain on hedge instruments, net of tax 190     190    
Net income (loss) 11,685       11,685  
Balance at end of period (in shares) at Mar. 30, 2024   78,558        
Balance at end of period at Mar. 30, 2024 $ 841,319 $ 852 791,710 (229) 266,301 (217,315)
Balance at beginning of period (in shares) at Dec. 30, 2023 78,311 78,311        
Balance at beginning of period at Dec. 30, 2023 $ 829,418 $ 848 788,967 (419) 254,616 (214,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 92          
Balance at end of period (in shares) at Sep. 28, 2024 78,691 78,691        
Balance at end of period at Sep. 28, 2024 $ 839,997 $ 854 801,848 0 254,708 (217,413)
Balance at beginning of period (in shares) at Mar. 30, 2024   78,558        
Balance at beginning of period at Mar. 30, 2024 841,319 $ 852 791,710 (229) 266,301 (217,315)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   73        
Issuance of common stock 354 $ 1 353      
Stock-based compensation 4,749   4,749      
Purchase of treasury stock (in shares)   (3)        
Purchase of treasury stock (54)         (54)
Unrealized gain on hedge instruments, net of tax 165     165    
Net income (loss) (3,125)       (3,125)  
Balance at end of period (in shares) at Jun. 29, 2024   78,628        
Balance at end of period at Jun. 29, 2024 843,408 $ 853 796,812 (64) 263,176 (217,369)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   67        
Issuance of common stock 531 $ 1 530      
Stock-based compensation 4,506   4,506      
Purchase of treasury stock (in shares)   (4)        
Purchase of treasury stock (44)         (44)
Unrealized gain on hedge instruments, net of tax 64     64    
Net income (loss) $ (8,468)       (8,468)  
Balance at end of period (in shares) at Sep. 28, 2024 78,691 78,691        
Balance at end of period at Sep. 28, 2024 $ 839,997 $ 854 $ 801,848 $ 0 $ 254,708 $ (217,413)